» Articles » PMID: 18053812

Inflammation and Insulin Resistance

Overview
Journal FEBS Lett
Specialty Biochemistry
Date 2007 Dec 7
PMID 18053812
Citations 434
Authors
Affiliations
Soon will be listed here.
Abstract

Obesity-induced chronic inflammation is a key component in the pathogenesis of insulin resistance and the Metabolic syndrome. In this review, we focus on the interconnection between obesity, inflammation and insulin resistance. Pro-inflammatory cytokines can cause insulin resistance in adipose tissue, skeletal muscle and liver by inhibiting insulin signal transduction. The sources of cytokines in insulin resistant states are the insulin target tissue themselves, primarily fat and liver, but to a larger extent the activated tissue resident macrophages. While the initiating factors of this inflammatory response remain to be fully determined, chronic inflammation in these tissues could cause localized insulin resistance via autocrine/paracrine cytokine signaling and systemic insulin resistance via endocrine cytokine signaling all of which contribute to the abnormal metabolic state.

Citing Articles

Perinatal adverse outcomes in twin pregnancies with preeclampsia complicated by distinct gestational diabetes subtypes.

Tang W, Kang Z, Zhao Y, Cai Q, Deng B, Zhou Z Acta Diabetol. 2025; .

PMID: 40088317 DOI: 10.1007/s00592-025-02444-z.


Association between C-reactive protein-triglyceride glucose index and testosterone levels among adult men: analyses of NHANES 2015-2016 data.

Zhang B, Gu Y, Chen Y, Xia W, Shao N, Zhuang Q Sex Med. 2025; 13(1):qfaf012.

PMID: 40061443 PMC: 11890278. DOI: 10.1093/sexmed/qfaf012.


The Impact of Sodium-Glucose Co-Transporter-2 Inhibition on Insulin Resistance and Inflammation in Patients with Type 2 Diabetes: A Retrospective Study.

Iordan L, Lazar S, Timar R, Popescu S, Sorescu T, Albai O Medicina (Kaunas). 2025; 61(2).

PMID: 40005325 PMC: 11857714. DOI: 10.3390/medicina61020209.


Targeting Ferroptosis in Parkinson's: Repurposing Diabetes Drugs as a Promising Treatment.

Duta C, Muscurel C, Dogaru C, Stoian I Int J Mol Sci. 2025; 26(4).

PMID: 40003982 PMC: 11855881. DOI: 10.3390/ijms26041516.


Non-Melanoma Skin Cancer: Assessing the Systemic Burden of the Disease.

Karampinis E, Koumaki D, Sgouros D, Nechalioti P, Toli O, Pappa G Cancers (Basel). 2025; 17(4).

PMID: 40002296 PMC: 11853326. DOI: 10.3390/cancers17040703.


References
1.
Cai D, Yuan M, Frantz D, Melendez P, Hansen L, Lee J . Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat Med. 2005; 11(2):183-90. PMC: 1440292. DOI: 10.1038/nm1166. View

2.
Ruan H, Hacohen N, Golub T, Van Parijs L, Lodish H . Tumor necrosis factor-alpha suppresses adipocyte-specific genes and activates expression of preadipocyte genes in 3T3-L1 adipocytes: nuclear factor-kappaB activation by TNF-alpha is obligatory. Diabetes. 2002; 51(5):1319-36. DOI: 10.2337/diabetes.51.5.1319. View

3.
Schottelius A, Mayo M, Sartor R, Baldwin Jr A . Interleukin-10 signaling blocks inhibitor of kappaB kinase activity and nuclear factor kappaB DNA binding. J Biol Chem. 1999; 274(45):31868-74. DOI: 10.1074/jbc.274.45.31868. View

4.
Di Gregorio G, Yao-Borengasser A, Rasouli N, Varma V, Lu T, Miles L . Expression of CD68 and macrophage chemoattractant protein-1 genes in human adipose and muscle tissues: association with cytokine expression, insulin resistance, and reduction by pioglitazone. Diabetes. 2005; 54(8):2305-13. DOI: 10.2337/diabetes.54.8.2305. View

5.
Iwasaki A, Medzhitov R . Toll-like receptor control of the adaptive immune responses. Nat Immunol. 2004; 5(10):987-95. DOI: 10.1038/ni1112. View